This review explores metformin's potential as an anti-aging therapy, highlighting its modulation of key aging-related pathways such as AMPK activation, mTOR inhibition, and IGF-1 signaling reduction. Preclinical studies demonstrate metformin's ability to extend lifespan and healthspan in various organisms. Observational data suggest reduced incidence of age-related diseases in metformin users.
